Back

Outcomes comparison between robotic and conventional mitral valve surgery: a systematic review and meta-analysis

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Epidemiology and artificial intelligence Minimally Invasive Surgery ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Ms Jenni Pratita

Fakultas Kedokteran Universitas Indonesia (FKUI), Central Jakarta (Indonesia)

7 More presentations in this session

Presentation thumbnail
Revascularization strategies versus optimal medical therapy in chronic coronary syndrome: a systematic review and network meta-analysis
Doctor M. Galli (Rome, IT)
Abstract Slides
Presentation thumbnail
Impact of surgical left atrial appendage closure during coronary bypass on clinical outcomes and readmissions
Doctor L. Wu (Greenville, US)
Abstract Slides
Presentation thumbnail
Artificial intelligence as a precision tool for predicting risk of in-hospital death after aortic valve replacement
Doctor A. Rosler (Porto Alegre, BR)
Abstract Slides
Presentation thumbnail
Large multinational evaluation of time to reintervention in patients undergoing bioprosthetic valve implantation during open heart surgery
Doctor T. Maller (Jerusalem, IL)
Abstract Slides
Presentation thumbnail
Artificial intelligence as a precision tool for predicting risk of in-hospital death after coronary artery bypass graft surgery
Doctor A. Rosler (Porto Alegre, BR)
Abstract Slides

Access the full session

Session thumbnail
Epidemiology and artificial intelligence

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
New onset of atrial fibrillation in aortic valve replacement by totally endoscopic approach versus minimal invasive aortic valve surgery
thumbnail
Congress Presentation
An uneventful triade – a case report of an extensive iatrogenic coronary dissection
thumbnail
Congress Presentation
Coronary stents and transcatheter therapies for structural heart disease: what have we learned in 2024?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources